(koh-MEH-trik)A drug used to treat progressive medullary thyroid cancer that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer.
Mechanism of action
Cometriq blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Cometriq contains the active ingredient cabozantinib-s-malate. It is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor.
Learn more about Cometriq
Latest research - Cometriq
This WikiMD article Cometriq is a stub. If you are familiar with the topic Cometriq, you can help us. Paid editors welcome!
Cometriq is part of WikiMD's free ^articles!
^Cometriq (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.